Seeking Alpha

Cesca Therapeutics Inc (KOOL)

  • Jul. 16, 2013, 7:52 AM
    ThermoGenesis (KOOL) will merge with privately held TotipotentRx, a cell-based regenerative medicine company. KOOL will issue 12.491M shares worth some $18.6M to TotipotentRx. The deal is expected to close in Q4 and will be "transformative," in the words of KOOL CEO Matthew Plavan. (PR)
    | 1 Comment
Visit Seeking Alpha's
KOOL vs. ETF Alternatives
Company Description
Cesca Therapeutics Inc is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It develops and manufactures automated blood and bone marrow processing systems.